2019

1. Chiblak Sara*, Tang Zili*, Lemke Dieter*, Knoll Maximilian*, Dokic Ivana*, Warta Rolf*, Moustafa Mahmoud*, Mier Walter*, Brons Stephan*, Rapp Carmen*, Muschal Stefan*, Seidel Philipp*, Bendzsus Martin*, Adeberg Sebastian*, Wiestler Otmar D*, Haberkorn Uwe*, Debus Jürgen*, Herold-Mende Christel*, Wick Wolfgang*, Abdollahi Amir*: Carbon irradiation overcomes glioma radioresistance by eradicating stem cells and forming an antiangiogenic and immunopermissive niche. JCI insight 2019, 4:e123837.

2. Dimitrakopoulou-Strauss Antonia*: Monitoring of patients with metastatic melanoma treated with immune checkpoint inhibitors using PET-CT. Cancer immunology immunotherapy 2019, 68:813 - 822.

3. Dos Santos José Carlos, Schäfer Martin*, Bauder-Wüst Ulrike*, Lehnert Wencke, Leotta Karin*, Morgenstern Alfred, Kopka Klaus*, Haberkorn Uwe*, Mier Walter, Kratochwil Clemens: Development and dosimetry of 203Pb/212Pb-labelled PSMA ligands: bringing 'the lead' into PSMA-targeted alpha therapy? European journal of nuclear medicine and molecular imaging 2019, 46:1081 - 1091.

4. Eder Matthias*, Pavan Silvia, Bauder-Wüst Ulrike*, van Rietschoten Katerine, Baranski Ann-Christin*, Harrison Helen, Campbell Spencer, Stace Catherine L, Walker Edward H, Chen Liuhong, Bennett Gavin, Mudd Gemma, Schierbaum Ursula*, Leotta Karin*, Haberkorn Uwe*, Kopka Klaus*, Teufel Daniel P: Bicyclic Peptides as a New Modality for Imaging and Targeting of Proteins Overexpressed by Tumors. Cancer research 2019, 79:841 - 852.

5. Farolfi Andrea, Gafita Andrei, Calais Jeremie, Eiber Matthias, Afshar-Oromieh Ali, Spohn Fabian, Barbato Francesco, Weber Manuel, Ilhan Harun, Cervati Veronica, Wetter Axel, Hadaschik Boris, Briganti Alberto, Walz Jochen, Pianori Davide, Fanti Stefano, Haberkorn Uwe*, Herrmann Ken, Fendler Wolfgang Peter: 68Ga-PSMA-11 Positron Emission Tomography Detects Residual Prostate Cancer after Prostatectomy in a Multicenter Retrospective Study. The journal of urology 2019, 202:1174-1181.

6. Flechsig Paul, Lindner Thomas, Loktev Anastasia*, Roesch Saskia, Mier Walter, Sauter Max, Meister Michael, Herold-Mende Christel, Haberkorn Uwe*, Altmann Annette*: PET/CT Imaging of NSCLC with a αvβ6 Integrin-Targeting Peptide. Molecular imaging & biology 2019, 21:973 - 983.

7. Flechsig Paul, Zabeck Heike, Reubold Sebastian, Sachpekidis Christos*, Rathke Hendrik, Röhrich Manuel, Holland-Letz Tim*, Heussel Claus-Peter, Harms Alexander, Kauczor Hans-Ulrich, Haberkorn Uwe*, Giesel Frederik*: Impact of FDG-PET and Dynamic Contrast-Enhanced MRI in Comparison with DWI for N-Staging in Lung Cancer Patients. Iranian journal of radiology 2019, 16: e68638.

8. Giesel Frederik*, Knorr Karina, Spohn Fabian*, Will Leon, Maurer Tobias, Flechsig Paul, Neels Oliver*, Schiller Kilian, Amaral Horacio, Weber Wolfgang, Schwaiger Markus, Hohenfellner Markus, Kratochwil Clemens, Debus Juergen, Haberkorn Uwe*, Choyke Peter, Kramer Vasko, Kopka Klaus*, Eiber Matthias*: Detection efficacy of [18F]PSMA-1007 PET/CT in 251 Patients with biochemical recurrence after radical prostatectomy. Journal of nuclear medicine 2019, 60:362-368.

9. Giesel Frederik L, Heussel Claus Peter, Lindner Thomas, Röhrich Manuel, Rathke Hendrik, Kauczor Hans-Ulrich, Debus Jürgen, Haberkorn Uwe*, Kratochwil Clemens: FAPI-PET/CT improves staging in a lung cancer patient with cerebral metastasis. European journal of nuclear medicine and molecular imaging 2019, 46:1754 - 1755.

10. Giesel Frederik L, Kratochwil Clemens, Lindner Thomas, Marschalek Manfred M, Loktev Anastasia, Lehnert Wencke, Debus Jürgen*, Jäger Dirk, Flechsig Paul, Altmann Annette, Mier Walter, Haberkorn Uwe*: 68Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers. Journal of nuclear medicine 2019, 60:386 - 392.

11. Groener Jan Benedikt, Gelen Debora, Mogler Carolin, Herpel Esther, Toth Csaba, Kender Zoltan, Peichl Marco, Haufe Sabine, Haberkorn Uwe*, Sulaj Alba, Zemva Johanna, Kopf Stefan, Nawroth Peter Paul, Brune Maik, Rudofsky Gottfried: BRAF V600E and Retinoic Acid in Radioiodine-Refractory Papillary Thyroid Cancer. Hormone and metabolic research 2019, 51:69-75.

12. Haberkorn Uwe*, Czernin Johannes: A Conversation Between Uwe Haberkorn and Johannes Czernin. Journal of nuclear medicine 2019, 60:1495 - 1498.

13. Heckmann Markus B, Totakhel Belal, Finke Daniel, Anker Markus S, Müller-Tidow Carsten, Haberkorn Uwe*, Katus Hugo A, Lehmann Lorenz H: Evidence for a cardiac metabolic switch in patients with Hodgkin's lymphoma. ESC heart failure 2019, 6:824-829.

14. Ke Wang Eric, Xi liu, Sun Ruipei, Wang Fan, Pan Leyun*, Cheng Caixia*, Dimitrakopoulou-Strauss Antonia*, Zhe Nie, Li Yueping: A new deep learning model for assisted diagnosis on electrocardiogram. Mathematical biosciences and engineering 2019, 16:2481 - 2491.

15. Koerber Stefan A*, Will Leon, Kratochwil Clemens*, Haefner Matthias F*, Rathke Henrik, Kremer Christophe, Merkle Jonas, Herfarth Klaus*, Kopka Klaus*, Choyke Peter L, Holland-Letz Tim*, Haberkorn Uwe*, Debus Juergen*, Giesel Frederik*: 68Ga-PSMA-11 PET/CT in Primary and Recurrent Prostate Carcinoma: Implications for Radiotherapeutic Management in 121 Patients. Journal of nuclear medicine 2019, 60:234-240.

16. Kratochwil Clemens*, Fendler Wolfgang Peter, Eiber Matthias, Baum Richard, Bozkurt Murat Fani, Czernin Johannes, Delgado Bolton Roberto C, Ezziddin Samer, Forrer Flavio, Hicks Rodney J, Hope Thomas A, Kabasakal Levant, Konijnenberg Mark, Kopka Klaus*, Lassmann Michael, Mottaghy Felix M, Oyen Wim, Rahbar Kambiz, Schöder Heiko, Virgolini Irene, Wester Hans-Jürgen, Bodei Lisa, Fanti Stefano, Haberkorn Uwe*, Herrmann Ken: EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT). European journal of nuclear medicine and molecular imaging 2019, 46:2536-2544.

17. Kratochwil Clemens, Flechsig Paul, Lindner Thomas, Abderrahim Labidi, Altmann Annette*, Mier Walter, Adeberg Sabastian, Rathke Hendrik, Roehrich Manuel, Winter Hauke, Plinkert Peter, Marme Frederik, Lang Matthias, Kauczor Hans-Ulrich, Jaeger Dirk*, Debus Juergen*, Haberkorn Uwe*, Giesel Frederik: FAPI-PET/CT: Mean intensity of tracer-uptake (SUV) in 28 different kinds of cancer. Journal of nuclear medicine 2019, 60:801 - 805.

18. Kratochwil Clemens, Haberkorn Uwe*, Giesel Frederik L: Radionuclide Therapy of Metastatic Prostate Cancer. Seminars in nuclear medicine 2019, 49:313 - 325.

19. Lang Nina, Dick Julika, Slynko Alla, Schulz Carsten, Dimitrakopoulou-Strauss Antonia*, Sachpekidis Christos*, Enk Alexander H, Hassel Jessica C: Clinical significance of signs of autoimmune colitis in 18F-fluorodeoxyglucose positron emission tomography-computed tomography of 100 stage-IV melanoma patients. Immunotherapy 2019, 11:667 - 676.

20. Liolios Christos*, Sachpekidis Christos*, Schäfer Martin*, Kopka Klaus*: Bispecific Radioligands targeting Prostate Specific Membrane Antigen (PSMA) and Gastrin Releasing Peptide receptors (GRPr) on the surface of prostate cancer cells. Journal of labelled compounds and radiopharmaceuticals 2019, 62:510-522.

21. Loktev Anastasia, Lindner Thomas, Burger Eva-Maria, Altmann Annette*, Giesel Frederik, Kratochwil Clemens, Debus Jürgen*, Marmé Frederik, Jäger Dirk, Mier Walter, Haberkorn Uwe*: Development of Fibroblast Activation Protein-Targeted Radiotracers with Improved Tumor Retention. Journal of nuclear medicine 2019, 60:1421 - 1429.

22. Majenka P., Hoffmann M., Rötzer I., Dimitrakopoulou-Strauss A.*, Koschny R., Longerich T., Enk A., Hassel J. C.: Diet-dependent toxicity of ipilimumab in metastatic melanoma. European journal of cancer 2019, 106:220 - 224.

23. Müller Martin*, Altmann Annette*, Sauter Max, Lindner Thomas, Jäger Dirk, Rathke Hendrik, Herold-Mende Christel, Marmé Frederik, Babich John, Mier Walter, Haberkorn Uwe*: Preclinical evaluation of peptide-based radiotracers for integrin αvβ6-positive pancreatic carcinoma. Nuklearmedizin 2019, 58:309-318.

24. Papamichail Dimitris*, Hog Robert*, Goldschmidt Hartmut, Dimitrakopoulou-Strauss Antonia*: Imaging Features of Multiple Myeloma Extramedullary Lesions in the Liver with 18F-FDG PET/CT, Contrast-Enhanced CT and MRI. Diagnostics 2019, 9:179

25. Rathke Hendrik, Flechsig Paul, Mier Walter, Bronzel Marcus, Mavriopoulou Eleni, Hohenfellner Markus, Giesel Frederik Lars, Haberkorn Uwe*, Kratochwil Clemens: Dosimetry Estimate and Initial Clinical Experience with 90Y-PSMA-617. Journal of nuclear medicine 2019, 60:806 - 811.

26. Rathke Hendrik, Kratochwil Clemens, Hohenberger Ralph, Giesel Frederik Lars, Bruchertseifer Frank, Flechsig Paul, Morgenstern Alfred, Hein Matti, Plinkert Peter, Haberkorn Uwe*, Bulut Olcay Cem: Initial clinical experience performing sialendoscopy for salivary gland protection in patients undergoing 225Ac-PSMA-617 RLT. European journal of nuclear medicine and molecular imaging 2019, 46:139 - 147.

27. Röhrich M., Loktev A.*, Wefers A., Paech D., Adeberg S., Windisch P., Hielscher T.*, Flechsig P., Floca R.*, Debus J.*, Deimling A.*, Lindner T., Haberkorn Uwe*: Fibroblast Activation Protein specific PET: A novel imaging method for IDH-wildtype Glioblastomas and IDH-mutant Gliomas. NuklearMedizin 2019 2019, 58:123-124.

28. Röhrich Manuel*, Loktev Anastasia*, Wefers Annika K*, Altmann Annette*, Paech Daniel*, Adeberg Sebastian, Windisch Paul, Hielscher Thomas*, Flechsig Paul*, Floca Ralf*, Leitz Dominik, Schuster Julius P*, Huber Peter E*, Debus Jürgen, von Deimling Andreas*, Lindner Thomas*, Haberkorn Uwe*: IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT. European journal of nuclear medicine and molecular imaging 2019, 46:2569-2580.

29. Ronellenfitsch Ulrich, Karampinis Ioannis, Dimitrakopoulou-Strauss Antonia*, Sachpekidis Christos*, Jakob Jens, Kasper Bernd, Nowak Kai, Pilz Lothar, Attenberger Ulrike, Gaiser Timo, Derigs Hans-Günther, Schwarzbach Matthias, Hohenberger Peter: Preoperative Pazopanib in High-Risk Soft Tissue Sarcoma: Phase II Window-of Opportunity Study of the German Interdisciplinary Sarcoma Group (NOPASS/GISG-04). Annals of surgical oncology 2019, 26:1332 - 1339.

30. Sachpekidis Christos*, Goldschmidt Hartmut, Dimitrakopoulou-Strauss Antonia*: Positron Emission Tomography (PET) Radiopharmaceuticals in Multiple Myeloma. Molecules 2019, 25:134

31. Sachpekidis Christos*, Karampinis Ioannis, Jakob Jens, Kasper Bernd, Nowak Kai, Pilz Lothar, Attenberger Ulrike, Gaiser Timo, Derigs Hans-Günter, Schwarzbach Matthias, Hohenberger Peter, Dimitrakopoulou-Strauss Antonia*, Ronellenfitsch Ulrich: Neoadjuvant Pazopanib Treatment in High-Risk Soft Tissue Sarcoma: A Quantitative Dynamic 18F-FDG PET/CT Study of the German Interdisciplinary Sarcoma Group. Cancers 2019, 11:790

32. Sachpekidis Christos*, Kopp-Schneider Annette*, Hakim-Meibodi Lara, Dimitrakopoulou-Strauss Antonia*, Hassel Jessica C: 18F-FDG PET/CT longitudinal studies in patients with advanced metastatic melanoma for response evaluation of combination treatment with vemurafenib and ipilimumab. Melanoma research 2019, 29:178 - 186.

33. Sachpekidis Christos*, Larribère Lionel*, Kopp-Schneider Annette*, Hassel Jessica C, Dimitrakopoulou-Strauss Antonia*: Can benign lymphoid tissue changes in 18F-FDG PET/CT predict response to immunotherapy in metastatic melanoma?315. Cancer immunology immunotherapy 2019, 68:297-303.

34. Sachpekidis Christos*, Merz Maximilian, Kopp-Schneider Annette*, Jauch Anna, Raab Marc-Steffen, Sauer Sandra, Hillengass Jens, Goldschmidt Hartmut, Dimitrakopoulou-Strauss Antonia*: Quantitative dynamic 18F-FDG PET/CT before autologous stem cell transplantation predicts survival in multiple myeloma. Haematologica 2019, 104:e420-e423.

35. Schmeiser Heinz*, Muehlbauer Karl-Rudolf*, Mier Walter, Baranski Ann-Christin*, Neels Oliver*, Dimitrakopoulou-Strauss Antonia*, Schmezer Peter*, Kratochwil Clemens, Bruchertseifer Frank, Morgenstern Alfred, Kopka Klaus*: DNA damage in human whole blood caused by radiopharmaceuticals evaluated by the comet assay. Mutagenesis 2019, 34:239-244.

36. Vlachavas Efstathios-Iason, Pilalis Eleftherios, Papadodima Olga, Koczan Dirk, Willis Stefan, Klippel Sven, Cheng Caixia*, Pan Leyun*, Sachpekidis Christos*, Pintzas Alexandros, Gregoriou Vasilis, Dimitrakopoulou-Strauss Antonia*, Chatziioannou Aristotelis: Radiogenomic Analysis of F-18-Fluorodeoxyglucose Positron Emission Tomography and Gene Expression Data Elucidates the Epidemiological Complexity of Colorectal Cancer Landscape. Computational and structural biotechnology journal 2019, 17:177 - 185.

37. Wang Eric Ke, Zhang Xun, Pan Leyun*: Automatic Classification of CAD ECG Signals With SDAE and Bidirectional Long Short-Term Network. IEEE access 2019, 7:182873 - 182880.

38. Wang Eric Ke, Zhang Xun, Pan Leyun*, Cheng Caixia*, Dimitrakopoulou-Strauss Antonia*, Li Yueping, Zhe Nie: Multi-Path Dilated Residual Network for Nuclei Segmentation and Detection. Cells 2019, 8:499

39. Wüstemann Till, Haberkorn Uwe*, Babich John, Mier Walter: Targeting prostate cancer: Prostate-specific membrane antigen based diagnosis and therapy. Medicinal research reviews 2019, 39:40 - 69.

40. Zippel Claus*, Neels Oliver*, Hennrich Ute*, Giesel Frederik*, Kopka Klaus*: [Initiation of clinical multicentre studies with local radiotracer production - Regulatory environment and radiopharmaceutical-organisational aspects]. Nuklearmedizin 2019, 58:77 - 85.